Electrochemotherapy For The Treatment Of Breast Cancer That Has Spread to the Skin
Status:
Withdrawn
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
Electroporation combined with chemotherapy (ECT) has been shown to be an effective treatment
for breast cancer that has spread to skin. In routine clinical practise, ECT is offered to
patients when all other treatment options have been exhausted. This study tests the
hypothesis that early treatment with ECT may result in improved local control of skin
metastases, improved quality of life and reduced health care costs. Patients are randomised
to either ECT given as early as possible in the course of the disease or delaying ECT for at
least 6 months.